RecruitingNCT06733766
Ultrasound-guided Thermal Ablation for Recurrent Thyroid Cancer
Ultrasound-guided Thermal Ablation for Recurrent Thyroid Cancer: A Multicenter Study
Sponsor
Chinese PLA General Hospital
Enrollment
300 participants
Start Date
Dec 9, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
To evaluate the long-term outcomes of ultrasound-guided thermal ablation for recurrent thyroid cancer
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This study is looking at a minimally invasive procedure called thermal ablation — using heat delivered through a needle guided by ultrasound — to treat thyroid cancer that has come back after surgery.
**You may be eligible if...**
- You previously had thyroid surgery (thyroidectomy) for thyroid cancer
- Your cancer has returned, and a biopsy confirmed it is malignant
- There is no evidence the cancer has spread to other organs (no distant metastases)
- You have been followed up for at least 12 months after surgery
**You may NOT be eligible if...**
- You have a blood clotting disorder
- You have serious heart, breathing, liver, or kidney problems
- The vocal cord on the side opposite your tumor is not working properly
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDUREultrasound-guided thermal ablation
microwave ablation, radiofrequency ablation, laser ablation
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06733766